A5046661157- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Treatment and Pharmacology
- Economic and Financial Impacts of Cancer
- Lung Cancer Research Studies
- Chemotherapy-induced cardiotoxicity and mitigation
- Colorectal Cancer Treatments and Studies
- PARP inhibition in cancer therapy
- Neuroendocrine Tumor Research Advances
- Cancer Mechanisms and Therapy
- Gastrointestinal Tumor Research and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
Pontificia Universidad Javeriana
2016-2019
Jackson Memorial Hospital
2017
University of Miami
2017
The Ohio State University
2017
Universidad Peruana Cayetano Heredia
2017
Cancer Treatment Centers of America
2017
Hospital Universitario San Ignacio
2016
University of Pennsylvania
2016
Hospital of the University of Pennsylvania
2016
This is the case of an 84-year-old woman diagnosed with Stage IVb colon adenocarcinoma (CRC) metastatic to liver, retroperitoneum, anastomotic site, and distal rectal sigmoid colon. She experienced intolerable side effects systemic chemotherapy 5-fluorouracil bevacizumab, as well disease progression. Next generation sequencing her tumor was ordered, further discussion malignancy's genomic information took place at a multidisciplinary molecular board. The patient had mutations in KRAS...
This manuscript reports on a patient with metastatic gastrointestinal stromal tumor (GIST) refractory to standard first-line treatment, who underwent gallium-68 scan based pre-clinical data of somatostatin receptor (SSTR) expression in such tumors. The DOTATATE determined significant avidity as hypothesized, suggesting that this imaging modality may be used an option for diagnostic and follow-up purposes GIST patients. In addition, peptide receptor-mediated radiotherapy (177Lu-PPRT) via SSTR...
TPS717 Background: Precision oncology encompasses the implementation of high level evidence disease-specific and biomarker-driven diagnostic treatment recommendations for optimized cancer care. Artificial Intelligence (AI), telemedicine value-based care may optimize clinical trial enrollment (CTE) overall cost-benefit. This ongoing, international registry pts evaluates feasibility utility an AI-based precision matching tool, powered by a virtual tumor boards (VTB) program, its impact on with...